In vivo tumorigenicity of glioblastoma transfected with interleukin-2 and/or interleukin-3 gene
In vivo tumorigenicity of glioblastoma transfected with interleukin-2 and/or interleukin-3 gene
摘要
The prognosis for patients with primarymalignant glioma remains poor, in spite of a varietyof different forms of treatments. Broad suppressionof humoral and cell-mediated immunity is found inpatients with malignant gliomas. Interleukin-2 (IL-2)production and IL-2 receptor expression are
出处
《中国实验血液学杂志》
CAS
CSCD
1997年第3期297-297,共1页
Journal of Experimental Hematology
-
1FU Jun,LIU Zhi-gang,LIU Xiao-mei,CHEN Fu-rong,SHI Hong-liu,PANG Jesse Chung-sean,NG Ho-keung,CHEN Zhong-ping.Glioblastoma stem cells resistant to temozolomide-induced autophagy[J].Chinese Medical Journal,2009(11):1255-1259. 被引量：20
-
2孙红军,荔志云.Notchl通路介导胶质瘤干细胞耐药的研究进展[J].中华神经外科杂志,2016,32(11):1186-1188.
-
3杨群英.Temozolomide chemotherapy based on MGMT protein expression for patients with malignant gliomas:a report of 40 cases[J].外科研究与新技术,2011(3):207-207.
-
4Sun, B. C.,Gao, Y.,Deng, L.,Li, G. Q.,Cheng, F.,Wang, X. H. Nanjing Med Univ, Liver Transplantat Ctr, Affiliated Hosp 1, Jiangsu 210029, Peoples R China. Nanjing Med Univ, Liver Transplantat Ctr, Ctr Canc, Jiangsu 210029, Peoples R China..The level of oncogene H-Ras correlates with tumorigenicity and malignancy[J].南京医科大学学报（自然科学版）,2008,28(6):800-800. 被引量：3
-
5于敏,曹雪涛,章卫平,杨建民,孟沛霖.In vitro proliferation and in vivo tumorigenicity of IL-2 gene and IL-3 gene co-transfected leukemia cells[J].Journal of Medical Colleges of PLA(China),1997,12(2):96-99.
-
6石淑文,郭淑芬.人Glioblastoma/HHT多药耐药细胞系的建立及维拉帕米对耐药性的逆转作用[J].实用肿瘤杂志,1998,13(5):272-275.
-
7Sathornsumetee S Rich JN.New treatment strategies for malignant gliomas[J].中国神经肿瘤杂志,2006,4(2):92-92. 被引量：5
-
8孙红军,姜拓之,荔志云.胶质瘤耐药机制的研究进展[J].西北国防医学杂志,2016,37(6):400-403. 被引量：1
-
9梁晨,郭世文.贝伐单抗治疗复发性恶性胶质瘤的临床研究进展[J].中华神经外科疾病研究杂志,2012,11(4):382-384. 被引量：3
-
10李朝晖,韩亮,魏君.胶质母细胞瘤分子靶向治疗研究进展[J].国际神经病学神经外科学杂志,2016,43(6):586-590. 被引量：2
